Abris acquires ITP

Abris is investing in the firm via Nept Holdings, a subsidiary of the Abris CEE Midmarket III vehicle.

The deal marks the fifth investment from the flagship buyout fund, which held a final close on €500m in autumn 2017.

With Abris as strategic investor, ITP plans on expanding into the aesthetic medicine markets in China and the US.

Company
Founded in 2006 by Italian entrepreneur and current CEO Gabriele Drigo, ITP is a Warsaw-headquartered biomedical company that offers distribution of medical devices and wellness equipment, and manufactures soft tissue fillers and organic cosmeceuticals.

ITP became the distributor for Palomar Medical Technologies, a manufacturer of aesthetic medicine equipment, in 2009. The company broadened its offering into the wellness segment in 2013, becoming the Polish distributor of Italian brand Technogym, supplying gyms, fitness clubs and hospitals. It acquired MatexLab, the Swiss producer and distributor of hyaluronic fillers, in 2015.

ITP posted a revenue of PLN 120m in 2017.

People
Abris – Pawel Gierynski (managing partner).
ITP – Gabriele Drigo (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• CEE
• Healthcare
• Poland
• Abris Capital Partners